TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11939919

Group type: EXPERIMENTAL
Intervention: Slow rewarming strategy (0.24 degrees C/min)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fast rewarming strategy (0.5 degrees C/min)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison of both rewarming strategies
Number of subjects: 50
Study: 9791528

Group type: EXPERIMENTAL
Intervention: Individual Psychological Support (IPS)
Number of subjects: 527

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 527
Study: 7626351

Group type: COMPARATOR
Intervention: Warfarin treatment (group 2)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: No antithrombotic medication (group 1)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Aspirin treatment (group 3)
Number of subjects: 87
Study: 2570535

Group type: EXPERIMENTAL
Intervention: Fentanyl (20 micrograms/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sufentanil (4 micrograms/kg)
Number of subjects: 45
Study: 30540617

Group type: EXPERIMENTAL
Intervention: LAI risperidone
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: LAI SGAs
Number of subjects: 5
Study: 25659140

Group type: EXPERIMENTAL
Intervention: Thermistors
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: iButtons
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Infrared thermometer
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Infrared camera
Number of subjects: 30
Study: 25088865

Group type: EXPERIMENTAL
Intervention: Midurethral sling procedures (TOMUS and E-TOMUS)
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Concomitant repair for symptomatic stage 2 POP at index sling surgery
Number of subjects: 597

Group type: COMPARATOR
Intervention: Asymptomatic stage 2 POP
Number of subjects: 597
Study: 21671102

Group type: EXPERIMENTAL
Intervention: Limited practice session
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolonged practice session
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single practice session
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple practice sessions
Number of subjects: 0
Study: 20394251

Group type: COMPARATOR
Intervention: Epidural analgesia using bupivacaine plus fentanyl
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PCA remifentanil 0.5 microg/kg as a loading bolus, 0.25 microg/kg PCA bolus, continuous infusion of 0.05 microg/kg/min
Number of subjects: 30
Study: 17611205

Group type: EXPERIMENTAL
Intervention: Barometric pressures at 8000 ft
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Barometric pressures at 7000 to 8000 ft
Number of subjects: 502

Group type: COMPARATOR
Intervention: Barometric pressures at all altitudes
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Exposure duration of 3 to 9 hours
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Participants older than 60 years
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Serious adverse events
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Adverse events related to study exposures
Number of subjects: 502
Study: 15721762

Group type: EXPERIMENTAL
Intervention: O2‐SPECT
Number of subjects: 26
Study: 12147804

Group type: EXPERIMENTAL
Intervention: Fluvastatin (20 mg/day p.o.)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 10218753

Group type: EXPERIMENTAL
Intervention: Physician nutrition counseling training plus an office-support program (Group 3)
Number of subjects: 1162

Group type: COMPARATOR
Intervention: Usual care (Group 1)
Number of subjects: 1162
Study: 7619749

Group type: COMPARATOR
Intervention: Cisplatin (120 mg/sqm day 1) + etoposide (100 mg/sqm days 1-3) every 3 weeks (PE)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Cisplatin (120 mg/sqm every 4 weeks) + mitomycin-C (8 mg/sqm days 1-29-71) + vindesine (3 mg/sqm days 1-8-15-22) (MVP)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Cisplatin (120 mg/sqm day 1) + mitomycin-C (6 mg/sqm day 1) + ifosfamide (3 mg/sqm day 2) every 3 weeks (MIC)
Number of subjects: 393
Study: 2797631

Group type: EXPERIMENTAL
Intervention: 20 mg of aspirin per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 60 mg of aspirin per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 80 mg of aspirin per day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 402800

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 31729443

Group type: EXPERIMENTAL
Intervention: Biophysical propensity scales as input features for ML methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One-hot encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-linear ML methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Learning problem-specific embeddings
Number of subjects: 0
Study: 29076670

Group type: EXPERIMENTAL
Intervention: Nigella sativa 1g twice a day for 12 weeks
Number of subjects: 70
Study: 26063318

Group type: EXPERIMENTAL
Intervention: Shenzhu Guanxin Recipe (SGR)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Standard Western Medicine Treatment (SWMT)
Number of subjects: 187
Study: 23952636

Group type: EXPERIMENTAL
Intervention: Tirasemtiv (375 mg daily for two weeks, with and without riluzole; 500 mg daily in two divided doses for three weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tirasemtiv
Number of subjects: 0
Study: 21730078

Group type: EXPERIMENTAL
Intervention: Stepped collaborative care intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 0
Study: 19197573

Group type: EXPERIMENTAL
Intervention: Thermal mineral water treatment
Number of subjects: 71

Group type: COMPARATOR
Intervention: Tap water treatment (Control)
Number of subjects: 71
Study: 17378201

Group type: EXPERIMENTAL
Intervention: Lianquan (RN 23) and para-Lianquan deep multi-needling (group B)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Single Lianquan RN 23 shallow needling (group A1)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Single Lianquan (RN 23) deep needling (group A2)
Number of subjects: 111
Study: 15505457

Group type: EXPERIMENTAL
Intervention: Intravenous morphine infusion (90 seconds)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo infusion (90 seconds)
Number of subjects: 8
Study: 11678162

Group type: EXPERIMENTAL
Intervention: Timolol GS (TIMOPTIC‐XE), 0.5% once daily
Number of subjects: 6

Group type: COMPARATOR
Intervention: Timolol maleate ophthalmic solution, 0.5% twice daily
Number of subjects: 6
Study: 9142351

Group type: EXPERIMENTAL
Intervention: Two models of brief family education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 0
Study: 7706505

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization (EMD)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Imaginal Exposure (Image Habituation Training - IHT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Applied Muscle Relaxation (AMR)
Number of subjects: 36
Study: 3311549

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nifedipine and Nicardipine
Number of subjects: 20
Study: 29298456

Group type: EXPERIMENTAL
Intervention: 17‐OHPC
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 26853333

Group type: EXPERIMENTAL
Intervention: Surgical staging followed by chemoradiation therapy (CRT) (arm A)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Clinical staging followed by chemoradiation therapy (CRT) (arm B)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Intensity modulated radiation therapy (IMRT)
Number of subjects: 240

Group type: COMPARATOR
Intervention: 3-dimensional technique
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 240
Study: 26178889

Group type: EXPERIMENTAL
Intervention: Zoledronate (5 mg intravenously per year for two years)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (no zoledronate)
Number of subjects: 110
Study: 22396248

Group type: EXPERIMENTAL
Intervention: Lifestyle maintenance programme (n = 112)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard care (n = 98)
Number of subjects: 210
Study: 21907496

Group type: EXPERIMENTAL
Intervention: Internet program for smoking cessation (6 months duration, with 1 to 7 individual counseling sessions)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Assessment only control group
Number of subjects: 477
Study: 18179480

Group type: EXPERIMENTAL
Intervention: Behavioral intervention consisting of twelve individual sessions (9 home sessions and 3 telephone sessions) and five telephone support-group sessions.
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group received two 'check in' phone calls.
Number of subjects: 112
Study: 16731539

Group type: EXPERIMENTAL
Intervention: TAM‐LHRHa (LHRH agonist plus tamoxifen)
Number of subjects: 333

Group type: COMPARATOR
Intervention: FEC50 (fluorouracil, epirubicin, cyclophosphamide)
Number of subjects: 333
Study: 15382712

Group type: EXPERIMENTAL
Intervention: Group counseling with visual aids
Number of subjects: 1054

Group type: COMPARATOR
Intervention: Group counseling without visual aids
Number of subjects: 1054
Study: 11270525

Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasonography (Group B)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Physical examination only (Group A)
Number of subjects: 124
Study: 9037322

Group type: EXPERIMENTAL
Intervention: Hypertension (systolic and diastolic)
Number of subjects: 950
Study: 8143951

Group type: EXPERIMENTAL
Intervention: 20 g of alcohol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Lundh test meal with water
Number of subjects: 16
Study: 3548626

Group type: EXPERIMENTAL
Intervention: Oral ketoconazole, 400 mg/d
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 31549147

Group type: EXPERIMENTAL
Intervention: 12-month treatment regimen containing clofazimine (CFZ)
Number of subjects: 135

Group type: COMPARATOR
Intervention: 18-month treatment regimen (control group)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 135
Study: 28902669

Group type: EXPERIMENTAL
Intervention: ALPPS
Number of subjects: 97

Group type: COMPARATOR
Intervention: TSH
Number of subjects: 97
Study: 27423382

Group type: EXPERIMENTAL
Intervention: MMRV+MenC
Number of subjects: 716

Group type: COMPARATOR
Intervention: MMRV
Number of subjects: 716

Group type: COMPARATOR
Intervention: MenC
Number of subjects: 716
Study: 23183371

Group type: EXPERIMENTAL
Intervention: Femoral component implanted in 4° flexion (F)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Femoral component implanted in a neutral position (C)
Number of subjects: 39
Study: 22513429

Group type: EXPERIMENTAL
Intervention: High-tie vascular transections
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-tie vascular transections
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-tie vascular transections after secondary left colic artery division
Number of subjects: 30
Study: 21171261

Group type: COMPARATOR
Intervention: Tamsulosin 0.2 mg qd
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Combination of tamsulosin and tolterodine 2 mg bid
Number of subjects: 184
Study: 18487001

Group type: COMPARATOR
Intervention: Passive Cycling Movements (PCMs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Transcutaneous Electrical Muscle Stimulation (TEMS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: No Intervention (NI)
Number of subjects: 10
Study: 16162055

Group type: EXPERIMENTAL
Intervention: White Identity Centrality Implicit Association Test (WICIAT)
Number of subjects: 0
Study: 12593316

Group type: EXPERIMENTAL
Intervention: Gentle human touch nursing intervention
Number of subjects: 0
Study: 10499246

Group type: EXPERIMENTAL
Intervention: Postmastectomy locoregional radiation therapy
Number of subjects: 0
Study: 7798683

Group type: COMPARATOR
Intervention: Active postexposure prophylaxis with two different vaccines
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Active postexposure prophylaxis
Number of subjects: 166

Group type: COMPARATOR
Intervention: Passive-active immunoprophylaxis with high-dose hepatitis B immune globulin
Number of subjects: 166
Study: 2687639

Group type: EXPERIMENTAL
Intervention: Weight loss program
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 77
Study: 30959314

Group type: EXPERIMENTAL
Intervention: Clarithromycin treatment (14-day duration)
Number of subjects: 3977

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 3977

Group type: EXPERIMENTAL
Intervention: Both groups (clarithromycin and placebo)
Number of subjects: 3977
Study: 27730425

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR) injections and short pulse focal/grid laser photocoagulation
Number of subjects: 21
Study: 26176347

Group type: EXPERIMENTAL
Intervention: N(G)‐monomethyl‐L‐arginine (L‐NMMA)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Atropine (pre-treatment)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ondansetron (pre-treatment)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: L‐NMMA
Number of subjects: 26
Study: 22762238

Group type: EXPERIMENTAL
Intervention: Combination therapy of neuromuscular electrical stimulation (NMES) and balloon dilatation for 4 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine rehabilitation treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination therapy of NMES and balloon dilatation
Number of subjects: 60
Study: 21404198

Group type: EXPERIMENTAL
Intervention: Tubeless PCNL (group A)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Nephrostomy tube in place (group B)
Number of subjects: 200
Study: 19634161

Group type: EXPERIMENTAL
Intervention: Weekly carboplatin (AUC 1.5) and paclitaxel (45 mg/m2) with daily subcutaneous amifostine (500 mg)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Weekly carboplatin (AUC 1.5) and paclitaxel (45 mg/m2) without amifostine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Weekly carboplatin/paclitaxel with concomitant boost radiation
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Weekly carboplatin/paclitaxel with daily subcutaneous amifostine
Number of subjects: 58
Study: 17526165

Group type: EXPERIMENTAL
Intervention: Spleen-invigorating Prescription (SIP), orally, twice a day for 6 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group: intramuscular injection with human interferon alpha 1b, 3 times a week
Number of subjects: 60
Study: 15063521

Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS), 20 min/day for 90 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dummy machine (sham-exposed)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS) for delayed union treatment
Number of subjects: 30
Study: 11511482

Group type: EXPERIMENTAL
Intervention: Hospital-at-home schemes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard hospital care
Number of subjects: 0
Study: 9750575

Group type: EXPERIMENTAL
Intervention: Adult day care use
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no adult day care use)
Number of subjects: 0
Study: 7908268

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (budesonide) plus beta 2-agonist (salbutamol) 0.2 mg, t.i.d.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Beta 2-agonist (salbutamol) alone
Number of subjects: 58
Study: 3465425

Group type: EXPERIMENTAL
Intervention: Vigabatrin (gamma-vinyl GABA) at a daily dose of 2-4 g for 4 months
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Vigabatrin (gamma-vinyl GABA) at a daily dose of 2 g/day for 3 months
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Vigabatrin (gamma-vinyl GABA) at a daily dose of 4 g/day
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Vigabatrin (gamma-vinyl GABA) at a daily dose of 2 g/day
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30567490

Group type: EXPERIMENTAL
Intervention: Hydromorphone (0.2 mg/kg) + dezocine (0.5 mg/kg) + ramosetron (0.6 mg) diluted with normal saline to 200 mL
Number of subjects: 142

Group type: COMPARATOR
Intervention: Sufentanil (3.0 μg/kg) + dezocine (0.5 mg/kg) + ramosetron (0.6 mg) diluted with normal saline to 200 mL
Number of subjects: 142
Study: 26551550

Group type: EXPERIMENTAL
Intervention: Ramosetron 2.5 μg once daily for 12 weeks
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study: 23575360

Group type: EXPERIMENTAL
Intervention: Self-myofascial release (SMR) using a foam roller
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 10
Study: 23071202

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation in the first month after birth
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Glutamine group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation
Number of subjects: 52
Study: 20033720

Group type: EXPERIMENTAL
Intervention: Dichaotic music (auditory stress)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Classical music (auditory relaxation)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mental loading (mental arithmetic tasks)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Silence
Number of subjects: 8
Study: 18714795

Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulator (VNS)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Cerebral resective surgery
Number of subjects: 35

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 35
Study: 18626707

Group type: EXPERIMENTAL
Intervention: Controlled-release oxycodone administered 1 hour before surgery and 12 hours after the first administration
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Controlled-release oxycodone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo administered at the same intervals as oxycodone
Number of subjects: 50
Study: 15447698

Group type: EXPERIMENTAL
Intervention: Rizatriptan 5 mg (tablets)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Rizatriptan 5 mg (wafers)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 234
Study: 11228217

Group type: EXPERIMENTAL
Intervention: 3.75 mg triptorelin (conventional dose)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1.87 mg triptorelin (low dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both doses of triptorelin
Number of subjects: 60
Study: 9288279

Group type: EXPERIMENTAL
Intervention: Transcutaneous nerve stimulation (TNS)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nontreated controls
Number of subjects: 26
Study: 8491403

Group type: EXPERIMENTAL
Intervention: Food discussion
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Smell of food without sight or taste
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sham feeding
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sight and smell of food without taste
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sight of food without smell or taste
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control stimulus (discussion of neutral topics)
Number of subjects: 5
Study: 3535002

Group type: COMPARATOR
Intervention: Placebo/metoprolol 10 mg i.v. in patients with normal UAE
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo/metoprolol 10 mg i.v. in patients with incipient nephropathy
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg/24 h and hydroflumethiazid 25 mg/24 h during long-term treatment
Number of subjects: 16
Study: 31479384

Group type: EXPERIMENTAL
Intervention: High Motor Competence (HMC > 83)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Low Motor Competence (LMC < 83)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Females with Low Motor Competence (LMC)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Males
Number of subjects: 160
Study: 31029260

Group type: EXPERIMENTAL
Intervention: Map-assisted coding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual coding
Number of subjects: 0
Study: 28219674

Group type: EXPERIMENTAL
Intervention: 5% calcium sodium phosphosilicate toothpaste
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: 8% arginine/calcium carbonate toothpaste
Number of subjects: 135

Group type: COMPARATOR
Intervention: Regular fluoride toothpaste
Number of subjects: 135
Study: 25955642

Group type: EXPERIMENTAL
Intervention: EyeGiene mask
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: MGDRx Eye Bag
Number of subjects: 41

Group type: COMPARATOR
Intervention: Comparison of EyeGiene mask and MGDRx Eye Bag
Number of subjects: 41
Study: 24074511

Group type: EXPERIMENTAL
Intervention: Mini-open PLIF procedure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional PLIF procedure
Number of subjects: 40
Study: 21858097

Group type: EXPERIMENTAL
Intervention: SP+AQ
Number of subjects: 3014

Group type: COMPARATOR
Intervention: Placebos
Number of subjects: 3014
Study: 19442011

Group type: EXPERIMENTAL
Intervention: Full-endoscopic interlaminar approach
Number of subjects: 161

Group type: COMPARATOR
Intervention: Conventional microsurgical technique
Number of subjects: 161
Study: 16399110

Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (GM) administered intravenously at a dosage of 2.0 mg/kg/h starting 12 hours before surgery until postoperative day 2
Number of subjects: 60

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 60
Study: 15276504

Group type: EXPERIMENTAL
Intervention: Bradykinin infusion (25 microg for 7 minutes)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no bradykinin infusion)
Number of subjects: 41
Study: 11422001

Group type: EXPERIMENTAL
Intervention: Moclobemide (150 mg tablet every 12 h for 8 days) + Almotriptan (12.5 mg tablet on day 8)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Almotriptan (12.5 mg tablet on day 8)
Number of subjects: 12
Study: 9266290

Group type: EXPERIMENTAL
Intervention: Nisoldipine coat-core formulation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Immediate-release tablet
Number of subjects: 52

Group type: COMPARATOR
Intervention: Intravenous formulation
Number of subjects: 52